omniture
logo
Search
生華生物科技股份有限公司 SENHWA BIOSCIENCES INC.
Media Room

Photo News

rss
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference

Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference

2021-10-20 20:52 1574